A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocelluar carcinoma

Randomized Study of Autologous Cytokine-Induced Killer Cell Immunotherapy in Metastatic Renal Carcinoma

(2012) L. Liu et al.   CLINICAL CANCER RESEARCH

Surgical Resection of High-Risk Hepatocellular Carcinoma: Patient Selection, Preoperative Considerations, and Operative Technique

(2010) Mark J. Truty et al.   ANNALS OF SURGICAL ONCOLOGY

Management of Small Hepatocellular Carcinoma: A Review of Transplantation, Resection, and Ablation

(2010) William R. Jarnagin   ANNALS OF SURGICAL ONCOLOGY

Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery

(2010) Hui Li et al.   CYTOTHERAPY

Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC)

(2010) C. Hontscha et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients

(2010) Jing-Ting Jiang   WORLD JOURNAL OF GASTROENTEROLOGY

T Cell-Based Immunotherapy of Metastatic Renal Cell Carcinoma: Modest Success and Future Perspective

(2009) A. Shablak et al.   CLINICAL CANCER RESEARCH

Selection for Resection of Hepatocellular Carcinoma and Surgical Strategy: Indications for Resection, Evaluation of Liver Function, Portal Vein Embolization, and Resection

(2008) Dario Ribero et al.   ANNALS OF SURGICAL ONCOLOGY

In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity

(2008) R. Nishimura et al.   BLOOD

A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma

(2008) Dong Hui et al.   DIGESTIVE AND LIVER DISEASE

Sorafenib in Hepatocellular Carcinoma: Separating the Hype From the Hope

(2008) Robin K. Kelley et al.   JOURNAL OF CLINICAL ONCOLOGY

Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   JNCI-Journal of the National Cancer Institute

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

(2008) Ann-Lii Cheng et al.   LANCET ONCOLOGY

Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer

(2008) Kazuhiro Kakimi et al.   LUNG CANCER

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE